Specifications - Genentech Manufacturing Facility (NIMO), San Diego, CA, USA

Key Data
Order year	2002
Project type	New biologics manufacturing facility
Location	Oceanside, San Diego, CA, USA
Estimated investment	$375m
Completion	2005, sold off in June 2005 for $408m to Genentech Inc
Output chemicals	Monoclonal antibodies, Avastin (bevacizumab) (anticancer drug)
Key Players
Sponsor	Biogen Idec (now passed to Genentech Inc)
Designer	Ferguson Pape Baldwin
Contractors	DPR Construction, Emerson Process, Pacific Rim, Dynaelectric, CRB Consulting Engineers, Emerson Process Management and Siemens Building Technologies Inc
Financing	Biogen Idec (now passed to Genentech Inc)
Featured Suppliers
Applikon Biotechnology - Bioreactor Systems
Doctor Furnace - Environmental, Cold, Explosion and Clean Rooms